PANGENETICS
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases. PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employs a lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients
PANGENETICS
Social Links:
Industry:
Pharmaceutical
Founded:
1995-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.pangenetics.com
Total Employee:
11+
Status:
Active
Contact:
+31302537911
Total Funding:
52.71 M USD
Technology used in webpage:
Amazon Amazon Ohio Region
Current Employees Featured
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series C - PanGenetics
Crédit Agricole
Crédit Agricole investment in Series C - PanGenetics
Index Ventures
Index Ventures investment in Series C - PanGenetics
Biogen Idec
Biogen Idec investment in Series C - PanGenetics
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Series C - PanGenetics
Crédit Agricole
Crédit Agricole investment in Series B - PanGenetics
Index Ventures
Index Ventures investment in Series B - PanGenetics
ABN AMRO Fund
ABN AMRO Fund investment in Series B - PanGenetics
Index Ventures
Index Ventures investment in Seed Round - PanGenetics
Official Site Inspections
http://www.pangenetics.com
- Host name: ec2-54-209-32-212.compute-1.amazonaws.com
- IP address: 54.209.32.212
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
